4D Molecular Therapeutics, Inc. FDMT 深 滬
等待開盤 09-20 09:30:00 美东时间
13.50
-3.320
-19.74%
華盛通- 最 高17.41
- 今 開17.39
- 成交量 336.13万股
- 最 低 12.48
- 昨 收 16.82
- 總市值 6.72亿
- 52周最高 36.25
- 市盈率 靜 --
- 換手率 6.75%
- 52周最低 9.44
- 委 比 93.28%
- 總股本 4977.81万
- 歷史最高 55.11
- 量 比 4.98
- 振 幅 29.31%
- 歷史最低 5.32
- 每 手 1
- 風險率 6.55%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多4DMT Highlights Clinical Activity For 4D-150 And Design Of 4FRONT Phase 3 Program At 4D-150 Wet AMD Development Day
4D-150 demonstrated robust and durable clinical activity across all wet age-related macular degeneration (wet AMD) patient populations based on longest available follow-up dataIn broad population (Phase 2b), 70%
09-19 04:07
4DMT to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
EMERYVILLE, Calif., Aug. 12, 2024 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics...
08-12 20:00
4D Molecular Therapeutics Fabry candidate clinical hold lifted
The U.S. FDA has lifted a clinical hold on a phase 1/2 study of 4D Molecular Therapeutics' (NASDAQ:FDMT) 4D-310, its candidate for Fabry disease cardiomyopathy. The hold was disclosed in February 202...
08-10 02:46
4D Molecular Therapeutics Q2 EPS $(0.63) Beats $(0.71) Estimate, Sales $5.00K Down From $239.00K YoY
4D Molecular Therapeutics (NASDAQ:FDMT) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.71) by 11.27 percent. This is a 18.18 percent increase over losses of $(0.77) per
08-09 05:56
快讯 | 4d molecular therapeutics第二季度营业收入为0.5万美元，低于IBES估计的131万美元。
4D Molecular Therapeutics Q2 Revenue USD 5 Thousand Vs. IBES Estimate USD 1.31 ...
08-09 04:05
快讯 | 4d molecular therapeutics第二季度净利润为美元指数-3495.3万美元，低于IBES估计的美元指数-3770万美元。
4D Molecular Therapeutics Q2 Net Income USD -34.953 Million Vs. IBES Estimate U...
08-09 04:05
快讯 | 4d molecular therapeutics Q2营业费用美元指数4246.1万
4D Molecular Therapeutics Q2 Operating Expenses USD 42.461 Million
08-09 04:05
快讯 | 4d molecular therapeutics第二季度基础每股收益为美元指数-0.63
4D Molecular Therapeutics Q2 Basic EPS USD -0.63
08-09 04:05
美股牛股 | Tellurian涨超68%，获澳洲油气巨头9亿美元溢价收购；Cassava涨超27%
Tellurian涨超68%，获澳洲油气巨头9亿美元溢价收购；Cassava涨超27%，公司透露药物研究情况反应积极>>
07-23 19:36
Analysts’ Top Healthcare Picks: 4D Molecular Therapeutics (FDMT), Intuitive Surgical (ISRG)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
07-22 14:01
